Correlation Between Eli Lilly and Omeros

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and Omeros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and Omeros into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and Omeros, you can compare the effects of market volatilities on Eli Lilly and Omeros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of Omeros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and Omeros.

Diversification Opportunities for Eli Lilly and Omeros

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Eli and Omeros is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and Omeros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Omeros and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with Omeros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Omeros has no effect on the direction of Eli Lilly i.e., Eli Lilly and Omeros go up and down completely randomly.

Pair Corralation between Eli Lilly and Omeros

Considering the 90-day investment horizon Eli Lilly and is expected to under-perform the Omeros. But the stock apears to be less risky and, when comparing its historical volatility, Eli Lilly and is 5.95 times less risky than Omeros. The stock trades about -0.1 of its potential returns per unit of risk. The Omeros is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  400.00  in Omeros on September 17, 2024 and sell it today you would earn a total of  363.00  from holding Omeros or generate 90.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eli Lilly and  vs.  Omeros

 Performance 
       Timeline  
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Omeros 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Omeros are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical and fundamental indicators, Omeros reported solid returns over the last few months and may actually be approaching a breakup point.

Eli Lilly and Omeros Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eli Lilly and Omeros

The main advantage of trading using opposite Eli Lilly and Omeros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, Omeros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will offset losses from the drop in Omeros' long position.
The idea behind Eli Lilly and and Omeros pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities